Ascendis Pharma A/S (ASND)

212.84 +3.61 (+1.73%) USD  |  NASDAQ  |  Dec 24, 12:59
212.78 -0.06 (-0.03%) After-Hours: 13:59
More

Ascendis Pharma SG&A Expense (TTM): 446.44M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Novo Nordisk A/S 10.84B
Evaxion AS 6.00M
DBV Technologies SA 28.71M
Cellectis SA 19.93M
Biodexa Pharmaceuticals Plc 5.354M